![Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review | Journal of the American College of Cardiology Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/36a2bce0-e3bf-4936-9936-72dce914bb5b/fx1.jpg)
Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review | Journal of the American College of Cardiology
![Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life – GUAD Netz Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life – GUAD Netz](https://guad-netz.de/wp-content/uploads/2021/01/20210120-Skript-Bild2.png)
Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life – GUAD Netz
![Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study - ScienceDirect Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109700006938-gr1.gif)
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: A randomized, double-blind, placebo-controlled study - ScienceDirect
Yogesh Reddy on Twitter: "Pleased to see our indepth review of managing AF in HF in 2022 published. Welcome critiques given many grey areas. Management of Atrial Fibrillation Across the Spectrum of
![Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis | Scientific Reports Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsrep17731/MediaObjects/41598_2015_Article_BFsrep17731_Fig1_HTML.jpg)
Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis | Scientific Reports
![Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery | SpringerLink Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11748-019-01131-5/MediaObjects/11748_2019_1131_Fig1_HTML.png)
Incidence of postoperative atrial fibrillation in transdermal β-blocker patch users is lower than that in oral β-blocker users after cardiac and/or thoracic aortic surgery | SpringerLink
![PDF] Short-Term and Long-Term Effects of Bisoprolol on Chronic Heart Failure Related to Rheumatic Heart Disease and Atrial Fibrillation | Semantic Scholar PDF] Short-Term and Long-Term Effects of Bisoprolol on Chronic Heart Failure Related to Rheumatic Heart Disease and Atrial Fibrillation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8b24c31b8b5e8b4002ecd9f82e387981f70aa984/4-Table1-1.png)
PDF] Short-Term and Long-Term Effects of Bisoprolol on Chronic Heart Failure Related to Rheumatic Heart Disease and Atrial Fibrillation | Semantic Scholar
![Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41371-021-00505-8/MediaObjects/41371_2021_505_Fig1_HTML.png)
Certain beta blockers (e.g., bisoprolol) may be reevaluated in hypertension guidelines for patients with left ventricular hypertrophy to diminish the ventricular arrhythmic risk | Journal of Human Hypertension
![Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508713000798-gr1.jpg)
Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect
![Journal Update - Beta Blocker vs. Calcium Channel Blocker for Rate Control in Atrial Fibrillation - REBEL EM - Emergency Medicine Blog Journal Update - Beta Blocker vs. Calcium Channel Blocker for Rate Control in Atrial Fibrillation - REBEL EM - Emergency Medicine Blog](https://rebelem.com/wp-content/uploads/2015/07/Diltiazem-vs-Metoprolol-for-Afib-with-RVR.png)
Journal Update - Beta Blocker vs. Calcium Channel Blocker for Rate Control in Atrial Fibrillation - REBEL EM - Emergency Medicine Blog
![The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction](https://www.kjim.org/upload//thumbnails/kjim-2018-009f1.jpg)
The mortality benefit of carvedilol versus bisoprolol in patients with heart failure with reduced ejection fraction
![Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508713000798-gr2.jpg)
Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study - ScienceDirect
![Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study - ScienceDirect Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508716301022-gr1.jpg)
Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study - ScienceDirect
![Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/thumbnail/13051765:255v56n09-13051765tab02.gif)
Use of Bisoprolol in Heart Failure. The BISOCOR Observational Study | Revista Española de Cardiología
![JCM | Free Full-Text | Preference and Adherence to a Fixed-Dose Combination of Bisoprolol–Aspirin and Blood Pressure Control: Results of an Open-Label, Multicentre Study JCM | Free Full-Text | Preference and Adherence to a Fixed-Dose Combination of Bisoprolol–Aspirin and Blood Pressure Control: Results of an Open-Label, Multicentre Study](https://pub.mdpi-res.com/jcm/jcm-12-00017/article_deploy/html/images/jcm-12-00017-g001.png?1672140405)